Severe and uncommon involuntary movement disorders due to psychotropic drugs.
about
A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature ReviewOlanzapine-Induced Neuroleptic Malignant Syndrome.Neuroleptic malignant syndrome: a review for neurohospitalistsMovement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialLithium toxicity and neurologic effects: probable neuroleptic malignant syndrome resulting from lithium toxicityNeuroleptic malignant syndrome in cycloserine-induced psychosis.A retrospective study of extrapyramidal syndromes with second generation antipsychotics in the psychiatric unit of a tertiary care teaching hospitalAcute dystonia due to citalopram treatment: a case series.Neuroleptic malignant syndrome in elderly patients.Neuroleptic Malignant Syndrome Associated with Lithium Toxicity.Psychoeducation Improves Compliance and Outcome in Schizophrenia Without an Increase of Adverse Side Effects: A 7-Year Follow-up of the Munich PIP-Study.Delirium followed by neuroleptic malignant syndrome in rehabilitation setting. Is it anger reaction before discharge?Atypical neuroleptic malignant syndrome.Afebrile Neuroleptic Malignant Syndrome associated with Fluphenazine decanoate: A case reportOlanzapine-induced neuroleptic malignant syndrome in a patient with bipolar affective disorder: Does quetiapine holds the solution?Neuroleptic malignant syndrome in a patient with tongue cancer: a report of a rare case.Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis.Neuroleptic malignant syndrome-an 11-year longitudinal case-control study.Acute Abdomen with Ileus: A Heralding Presentation of Neuroleptic Malignant Syndrome
P2860
Q26778036-3396A6BC-D260-4651-8131-C9D907EB402CQ33676964-BA28B5F4-1280-4434-B93B-BA172F5BB09BQ34367132-BF6981F1-9934-4611-B601-74362EF533BAQ34480263-F4F544A8-6686-44C6-AAC6-89C6674BD091Q34642207-45B8B723-7722-435E-A08A-3D767530FBA0Q35669720-0ADD35F6-FFA2-401A-98E8-48B63041C9CFQ36366028-FB274479-5D44-4A5D-BAE7-351C38AECDEAQ36780509-79F889E2-04F1-49BD-90AB-CDA8BBE74505Q36787356-007CD8FA-289A-431B-A07A-1C7E813C3B1DQ37053645-FA39F0DB-29D8-4965-A45D-15A5B5F2D2BEQ37124952-0FAABD1A-C410-4222-B5C1-6B9D86C4AA23Q39222320-82A711EE-7049-4F4C-8785-D9E9F7DF3934Q40101519-59208BE5-3621-4C2E-B55B-75228FBA4B15Q40362616-E41ABCB7-4DFD-48D6-AC41-607FFBD7C808Q41763536-D7EAFC4E-884F-4145-90D3-7B9551438449Q43103870-60FB806A-11C6-4307-9B82-B869793B83C9Q47574204-AD4E6395-647B-46D0-8A67-71EFCBCF2635Q48634502-871D49FB-D040-4A48-9A6C-E4D6ABB9664EQ57493078-2CA39558-8CFF-4F87-9F6F-3FBCBC323F85
P2860
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@en
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@nl
type
label
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@en
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@nl
prefLabel
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@en
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@nl
P2093
P356
P1433
P1476
Severe and uncommon involuntary movement disorders due to psychotropic drugs.
@en
P2093
Grohmann R
Neundörfer G
Rustenbeck E
P304
P356
10.1055/S-2004-815511
P478
37 Suppl 1
P577
2004-03-01T00:00:00Z